Design Therapeutics (DSGN) Change in Acquisitions & Divestments (2020 - 2026)

Design Therapeutics' Change in Acquisitions & Divestments history runs 7 years deep, the most recent figure standing at $45.0 million for Q1 2026.

• In Q1 2026, Change in Acquisitions & Divestments fell 52.38% year-over-year to $45.0 million; the TTM figure through Mar 2026 stood at $265.4 million (down 12.26% YoY), while the FY2025 annual figure was $314.9 million, up 14.72% from the prior year.
• Change in Acquisitions & Divestments came in at $45.0 million for Q1 2026 at Design Therapeutics, down from $76.1 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $94.5 million in Q1 2025 to a low of $490000.0 in Q1 2022.
• A 5-year average of $59.1 million and a median of $66.2 million in 2024 frame the typical range for Change in Acquisitions & Divestments.
• On a YoY basis, Change in Acquisitions & Divestments climbed as much as 30020.0% in 2022 and fell as far as 98.26% in 2022.
• Design Therapeutics' Change in Acquisitions & Divestments stood at $60.2 million in 2022, then surged by 32.36% to $79.7 million in 2023, then fell by 16.97% to $66.2 million in 2024, then grew by 14.91% to $76.1 million in 2025, then sank by 40.85% to $45.0 million in 2026.
• According to Business Quant data, Change in Acquisitions & Divestments over the past three periods registered $45.0 million, $76.1 million, and $84.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison